UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 ___________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 12, 2001 Date of Report (Date of earliest event reported) APPLERA CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 1-4389 06-1534213 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File No.) Identification No.) 301 Merritt 7 Norwalk, Connecticut 06851 (Address of Principal Executive Offices, Including Zip Code) (203) 840-2000 (Registrant's telephone number, including area code) Item 5. Other Events and Regulation FD Disclosure. In a press release dated December 6, 2001 (the "Press Release"), Applera Corporation ("Applera") announced that it would webcast a meeting with the investment community on Wednesday, December 12, 2001 (the "Investor Meeting") to discuss Applera's Celera Genomics Group and Celera Diagnostics, a joint venture between Applera's Celera Genomics and Applied Biosystems groups. Attached hereto as Exhibit 99.1 and incorporated by reference herein is the text of the Press Release, and attached hereto as Exhibit 99.2 and incorporated by reference herein is the text of the presentations intended to be made by Applera at the Investor Meeting. Item 7. Financial Statements and Exhibits. (c) Exhibits. The following exhibits are filed with this Report: Exhibit No. Description 99.1 Press Release issued December 6, 2001 with respect to the Investor Meeting. 99.2 Text of presentations intended to be made at the Investor Meeting. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. APPLERA CORPORATION By:/s/ Thomas P. Livingston -------------------------- Thomas P. Livingston Secretary Dated: December 12, 2001 EXHIBIT INDEX Exhibit No. Description 99.1 Press Release issued December 6, 2001 with respect to the Investor Meeting. 99.2 Text of presentations intended to be made at the Investor Meeting.